The Middle East & Africa lateral flow assay market was valued at US$ 477.13 million in 2022 and is expected to reach US$ 722.68 million by 2030; it is estimated to register a CAGR of 5.3% from 2022 to 2030.
Smartphone-based biosensors in optical procedures involving mechanisms such as reflection, absorption, and fluorescence have been instrumental in diagnostics, medical, healthcare, food, and environmental monitoring applications. Artificial intelligence (AI) and machine learning are major technologies that drive this progress, providing real-time and highly accurate reads. With machine learning, reader software can quickly adapt to new tests launched by manufacturers. It can be potentially used as a low-cost, portable POC platform, especially suitable in remote low-income areas Africa.
Further, cloud-based systems may turn any tablet or smartphone into a universal digital reader, allowing healthcare organizations to perform lateral flow tests for the detection of any infection or marker on a large scale. This system allows any smartphone or tablet to become a universal digital reader, allowing healthcare organizations to roll out lateral flow testing for any disease or marker at scale. Furthermore, AI-driven innovative devices that can read a COVID-19 lateral flow diagnostic test using a user's smartphone have received special use approval from the Medicines and Healthcare Products Regulatory Agency (MHRA). Thus, AI integration and smartphone usage are likely to trigger the demand for lateral flow assays in the healthcare sector in the coming years.
The Middle East & Africa lateral flow assay market has been segmented into the UAE, Saudi Arabia, South Africa, and the Rest of the Middle East & Africa. The increase in the adoption of lateral flow assay-based rapid antigen test kits, a rise in the incidence of infectious diseases, and an upsurge in government initiatives in terms of funding and healthcare-related policies are among the factors contributing to the market growth in the region.
Saudi Arabia is the largest economy in the Middle East, excelling in the growth of various research and development programs nationwide. Saudi Arabia has been working on establishing itself as a hub of scientific excellence and innovation. Various expenditures on different research areas were initiated, resulting in a rise in new projects and applications that covers healthcare and science.
Strategic insights for the Middle East & Africa Lateral Flow Assay provides data-driven analysis of the industry landscape, including current trends, key players, and regional nuances. These insights offer actionable recommendations, enabling readers to differentiate themselves from competitors by identifying untapped segments or developing unique value propositions. Leveraging data analytics, these insights help industry players anticipate the market shifts, whether investors, manufacturers, or other stakeholders. A future-oriented perspective is essential, helping stakeholders anticipate market shifts and position themselves for long-term success in this dynamic region. Ultimately, effective strategic insights empower readers to make informed decisions that drive profitability and achieve their business objectives within the market.
Report Attribute | Details |
---|---|
Market size in 2022 | US$ 477.13 Million |
Market Size by 2030 | US$ 722.68 Million |
Global CAGR (2022 - 2030) | 5.3% |
Historical Data | 2020-2021 |
Forecast period | 2023-2030 |
Segments Covered |
By Product Type
|
Regions and Countries Covered | Middle East and Africa
|
Market leaders and key company profiles |
The geographic scope of the Middle East & Africa Lateral Flow Assay refers to the specific areas in which a business operates and competes. Understanding local distinctions, such as diverse consumer preferences (e.g., demand for specific plug types or battery backup durations), varying economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved areas or adapting their offerings to meet local demands. A clear market focus allows for more effective resource allocation, targeted marketing campaigns, and better positioning against local competitors, ultimately driving growth in those targeted areas.
The Middle East & Africa lateral flow assay market is categorized into product type, technique, test type, application, end user, and country.
Based on product type, the Middle East & Africa lateral flow assay market is bifurcated into kits & reagents and lateral flow readers. The kits & reagents segment held a larger Middle East & Africa lateral flow assay market share in 2022.
In terms of technique, the Middle East & Africa lateral flow assay market is segmented into sandwich assay, competitive assays, and multiplex detection assay. The sandwich assay segment held the largest Middle East & Africa lateral flow assay market share in 2022.
By test type, the Middle East & Africa lateral flow assay market is divided into lateral flow immunoassay and nucleic acid lateral flow assay. The lateral flow immunoassay segment held a larger Middle East & Africa lateral flow assay market share in 2022.
Based on application, the Middle East & Africa lateral flow assay market is categorized into clinical testing, veterinary diagnostics, food safety & environment testing, and drug development & quality testing. The clinical testing segment held the largest Middle East & Africa lateral flow assay market share in 2022.
By end user, the Middle East & Africa lateral flow assay market is segmented into hospitals and clinics, diagnostics laboratories, homecare, veterinary clinics, pharmaceutical & biotechnology companies, and others. The hospitals and clinics segment held the largest Middle East & Africa lateral flow assay market share in 2022.
By country, the Middle East & Africa lateral flow assay market is segmented into Saudi Arabia, South Africa, the UAE, Kuwait, Oman, Qatar, Egypt, and the Rest of Middle East & Africa. Saudi Arabia dominated the Middle East & Africa lateral flow assay market share in 2022.
F. Hoffmann-La Roche Ltd, Siemens Healthineers AG, Becton Dickinson and Co, PerkinElmer Inc, Hologic Inc, QIAGEN NV, bioMerieux SA, QuidelOrtho Corp, Abbott Laboratories, Merck KGaA, Bio-Rad Laboratories Inc, and Thermo Fisher Scientific Inc are some of the leading companies operating in the Middle East & Africa lateral flow assay market.
1. Abbott Laboratories
2. Becton Dickinson and Co
3. bioMerieux SA
4. Bio-Rad Laboratories Inc
5. F. Hoffmann-La Roche Ltd
6. Hologic Inc
7. Merck KGaA
8. PerkinElmer Inc
9. QIAGEN NV
10. QuidelOrtho Corp
11. Siemens Healthineers AG
12. Thermo Fisher Scientific Inc
The Middle East & Africa Lateral Flow Assay Market is valued at US$ 477.13 Million in 2022, it is projected to reach US$ 722.68 Million by 2030.
As per our report Middle East & Africa Lateral Flow Assay Market, the market size is valued at US$ 477.13 Million in 2022, projecting it to reach US$ 722.68 Million by 2030. This translates to a CAGR of approximately 5.3% during the forecast period.
The Middle East & Africa Lateral Flow Assay Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Middle East & Africa Lateral Flow Assay Market report:
The Middle East & Africa Lateral Flow Assay Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The Middle East & Africa Lateral Flow Assay Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the Middle East & Africa Lateral Flow Assay Market value chain can benefit from the information contained in a comprehensive market report.